Patents by Inventor Marie-Pierre Collin

Marie-Pierre Collin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160221965
    Abstract: The present application relates to novel 2,5-disubstituted 6-(trifluoromethyl)pyrimidin-4(3H)-one derivatives, to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases, and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for treatment and/or prevention of cardiovascular, renal, inflammatory and fibrotic diseases.
    Type: Application
    Filed: September 12, 2014
    Publication date: August 4, 2016
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Alexander STRAUB, Marie-Pierre COLLIN, Michael KOCH, Jutta MEYER, Karl-Heinz SCHLEMMER, Carl Friedrich NISING, Nicole BIBER, Sonja ANLAUF, Matthias Beat WITTWER
  • Patent number: 9206184
    Abstract: This invention relates to novel substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives having protein tyrosine kinase inhibitory activities, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating proliferative disorders, in particular cancer and tumor diseases.
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: December 8, 2015
    Assignee: BAYER INTELLECTUAL PROPERTY GmbH
    Inventors: Dirk Brohm, Melanie Heroult, Marie-Pierre Collin, Walter Hübsch, Mario Lobell, Klemens Lustig, Sylvia Grünewald, Ulf Bömer
  • Publication number: 20150080371
    Abstract: This invention relates to novel substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-fJ[1,2,4]triazin-4-amine derivatives having protein tyrosine kinase inhibitory activities, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating proliferative disorders, in particular cancer and tumor diseases.
    Type: Application
    Filed: December 11, 2012
    Publication date: March 19, 2015
    Inventors: Marie-Pierre Collin, Dirk Brohm, Melanie Heroult, Mario Lobell, Walter Hübsch, Klemens Lustig, Sylvia Grünewald, Ulf Bömer, Verena Vöhringer, Niels Lindner
  • Publication number: 20150031676
    Abstract: This invention relates to novel substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives having protein tyrosine kinase inhibitory activities, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating proliferative disorders, in particular cancer and tumor diseases.
    Type: Application
    Filed: February 20, 2013
    Publication date: January 29, 2015
    Applicant: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Mario Lobell, Walter Hübsch, Hartmut Schirok, Mélanie Héroult, Dirk Brohm, Marie-Pierre Collin, Sylvia Grünewald, Klemens Lustig, Ulf Bömer, Verena Vöhringer, Niels Lindner
  • Publication number: 20140336173
    Abstract: This invention relates to novel substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives of formula (I) wherein R1 is hydrogen, chloro, methyl or methoxy, R2 is hydrogen or methoxy, with the proviso that at least one of R1 and R2 is other than hydrogen, G1 represents chloro, (C1-C4)-alkyl, (C1-C4)-alkoxycarbonyl, 5-membered aza-heteroaryl, or the group —CH2—OR3, —CH2—NR4R5 or —C(?O)—NR4R6, and G2 represents chloro, cyano, (C1-C4)-alkyl, or the group —CR8AR8B—OH, —CH2—NR2R10, —C(?O)—NR11R12 or —CH2—OR15, having protein tyrosine kinase inhibitory activities, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating proliferative disorders, in particular cancer and tumor diseases.
    Type: Application
    Filed: December 10, 2012
    Publication date: November 13, 2014
    Inventors: Dirk Brohm, Melanie Heroult, Marie-Pierre Collin, Walter Hübsch, Mario Lobell, Klemens Lustig, Sylvia Grünewald, Ulf Bömer, Verena Vöhringer
  • Patent number: 5580490
    Abstract: Needle-shaped solid crystallites of specific LaCeTb phosphates, well suited for the production of green phosphors therefrom, are essentially pure white in color after calcination at 900.degree. C. and have the formula (I):La.sub.x Ce.sub.y Tb.sub.(1-x-y) PO.sub.4 (I)in which x and y are numbers, with x ranging from 0.4 to 0.6 and x+y being greater than 0.8.
    Type: Grant
    Filed: September 12, 1994
    Date of Patent: December 3, 1996
    Assignee: Rhone-Poulenc Chimie
    Inventors: Marie-Pierre Collin, Denis Huguenin, Anne-Marie le Govic
  • Patent number: 5562889
    Abstract: Novel cerium/lanthanum/terbium (LaCeTb) mixed phosphates, especially useful in luminescence for the production of green phosphors, have the formula (I):La.sub.x Ce.sub.y Tb.sub.1-x-y PO.sub.4in which X ranges from 0.4 to 0.6 and x+y is greater than 0.8, display a lightness (L.sup.*) of greater than 98% after calcination at a temperature above 700.degree. C. in air, and the cerium (IV) and/or terbium (IV) contents of which are very low, even after calcination in air at a temperature above 500.degree. C.
    Type: Grant
    Filed: November 1, 1994
    Date of Patent: October 8, 1996
    Assignee: Rhone-Poulenc Chimie
    Inventors: Marie-Pierre Collin, Denis Huguenin, Anne-Marie Le Govic
  • Patent number: 5340556
    Abstract: Novel cerium/lanthanum/terbium (LaCeTb) mixed phosphates, especially useful in luminescence for the production of green phosphors, have the formula (I):La.sub.x Ce.sub.y Tb.sub.1-x-y PO.sub.4in which x ranges from 0.4 to 0.6 and x+y is greater than 0.8, display a lightness (L*) of greater than 98% after calcination at a temperature above 700.degree. C. in air, and the cerium (IV) and/or terbium (IV) contents of which are very low, even after calcination in air at a temperature above 500.degree. C.
    Type: Grant
    Filed: February 4, 1992
    Date of Patent: August 23, 1994
    Assignee: Rhone-Poulenc Chimie
    Inventors: Marie-Pierre Collin, Denis Huguenin, Anne-Marie Le Govic
  • Patent number: 5314641
    Abstract: Needle-shaped solid crystallites of specific LaCeTb phosphates, well suited for the production of green phosphors therefrom, are essentially pure white in color after calcination at 900.degree. C. and have the formula (I):La.sub.x Ce.sub.y Tb.sub.(1-x-y) PO.sub.4 (I)in which x and y are numbers, with x ranging from 0.4 to 0.6 and x+y being greater than 0.8.
    Type: Grant
    Filed: July 20, 1992
    Date of Patent: May 24, 1994
    Assignee: Rhone-Poulenc Chimie
    Inventors: Marie-Pierre Collin, Denis Huguenin, Anne-Marie Le Govic